Skip to content

Aa.Pharma Oud-Turnhout: what changed

BE 0435.758.147NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€238,099
2024 · €213,844+€24,255
Equity
€436,264
2024 · €460,878-€24,613
Cash
€227,886
2024 · €114,876+€113,011
Balance sheet total
€1.9m
2024 · €2.1m-€176,585

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€167,990

    down €167,990 (-39.5%), from €425,247 to €257,256

    of which Other amounts receivable: -€192,819

  • Cash +€113,011

    up €113,011 (+98.4%), from €114,876 to €227,886

    mainly Net result for the year (+€238,099) and Receivables within one year (+€167,990)

  • Tangible fixed assets -€92,399

    down €92,399 (-7.6%), from €1.2m to €1.1m

    of which Land and buildings: -€54,233

  • Receivables after one year -€34,168

    down €34,168 (-100%), from €34,168 to €0

Equity and liabilities
  • Debts after one year -€119,076

    down €119,076 (-13.4%), from €889,046 to €769,970

  • Trade debts -€35,717

    down €35,717 (-18.3%), from €194,763 to €159,046

  • Reserves -€24,613

    down €24,613 (-6.4%), from €386,510 to €361,896

    of which Tax-exempt reserves: -€24,613

  • Other debts +€24,256

    up €24,256 (+10.1%), from €239,460 to €263,716

Income statement
  • Gross operating margin +€50,737

    up €50,737 (+8.1%), from €623,817 to €674,553

  • Staff costs +€25,390

    up €25,390 (+11.4%), from €222,053 to €247,443

  • Taxes +€8,214

    up €8,214 (+10.1%), from €80,940 to €89,154

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €213,844
Gross operating margin +€50,737
Staff costs -€25,390
Depreciation +€1,187
Other operating charges -€117
Financial income +€681
Financial charges +€5,370
Taxes -€8,214
Result 2025 €238,099
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€512,505
Investment €0
Financing -€399,495
Cash 2024 €114,876
Net result for the year +€238,099
Depreciation +€92,399
Receivables after one year +€34,168
Stocks and contracts -€4,100
Receivables within one year +€167,990
Deferred charges and accrued income -€863
Provisions -€8,204
Trade debts -€35,717
Tax, wage and social debts +€4,477
Other debts +€24,256
Debts after one year -€119,076
Current portion of long-term debt +€886
Short-term financial debts -€18,592
Contributions, distributions and other -€262,712
Cash 2025 €227,886
brings cash intakes cash out
Every line side by side 57 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,060,618 €1,884,033 -€176,585 -8.6%
Fixed assets 21/28 €1,215,039 €1,122,640 -€92,399 -7.6%
Tangible fixed assets 22/27 €1,210,039 €1,117,640 -€92,399 -7.6%
Land and buildings 22 €1,128,418 €1,074,185 -€54,233 -4.8%
Plant, machinery and equipment 23 €80,121 €42,804 -€37,317 -46.6%
Furniture and vehicles 24 €1,500 €650 -€850 -56.6%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €845,579 €761,394 -€84,185 -10.0%
Amounts receivable after more than one year 29 €34,168 €0 -€34,168 -100%
Other amounts receivable 291 €34,168 €0 -€34,168 -100%
Stocks and contracts in progress 3 €263,821 €267,921 +€4,100 +1.6%
Stocks 30/36 €263,821 €267,921 +€4,100 +1.6%
Amounts receivable within one year 40/41 €425,247 €257,256 -€167,990 -39.5%
Trade receivables 40 €151,849 €176,678 +€24,829 +16.4%
Other amounts receivable 41 €273,398 €80,578 -€192,819 -70.5%
Cash at bank and in hand 54/58 €114,876 €227,886 +€113,011 +98.4%
Deferred charges and accrued income 490/1 €7,467 €8,330 +€863 +11.6%
Total equity and liabilities 10/49 €2,060,618 €1,884,033 -€176,585 -8.6%
Equity 10/15 €460,878 €436,264 -€24,613 -5.3%
Contributions 10/11 €74,368 €74,368 = 0.0%
Capital 10 €74,368 €74,368 = 0.0%
Issued capital 100 €74,368 €74,368 = 0.0%
Reserves 13 €386,510 €361,896 -€24,613 -6.4%
Non-distributable reserves 130/1 €7,437 €7,437 = 0.0%
Legal reserve 130 €7,437 €7,437 = 0.0%
Tax-exempt reserves 132 €379,073 €354,459 -€24,613 -6.5%
Profit (loss) carried forward 14 €0 €0 =
Provisions and deferred taxes 16 €126,358 €118,153 -€8,204 -6.5%
Deferred taxes 168 €126,358 €118,153 -€8,204 -6.5%
Amounts payable 17/49 €1,473,383 €1,329,616 -€143,767 -9.8%
Amounts payable after more than one year 17 €889,046 €769,970 -€119,076 -13.4%
Financial debts 170/4 €889,046 €769,970 -€119,076 -13.4%
Amounts payable within one year 42/48 €584,337 €559,646 -€24,691 -4.2%
Current portion of amounts payable after more than one year 42 €83,103 €83,989 +€886 +1.1%
Financial debts 43 €18,592 €0 -€18,592 -100%
Credit institutions 430/8 €18,592 €0 -€18,592 -100%
Trade debts 44 €194,763 €159,046 -€35,717 -18.3%
Suppliers 440/4 €194,763 €159,046 -€35,717 -18.3%
Taxes, remuneration and social security 45 €48,419 €52,895 +€4,477 +9.2%
Taxes 450/3 €21,062 €22,594 +€1,532 +7.3%
Remuneration and social security 454/9 €27,357 €30,302 +€2,945 +10.8%
Other amounts payable 47/48 €239,460 €263,716 +€24,256 +10.1%
Remuneration, social security and pensions 62 €222,053 €247,443 +€25,390 +11.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €93,586 €92,399 -€1,187 -1.3%
Other operating charges 640/8 €3,758 €3,875 +€117 +3.1%
Gross operating margin 9900 €623,817 €674,553 +€50,737 +8.1%
Operating profit (loss) 9901 €304,420 €330,836 +€26,416 +8.7%
Financial income 75/76B €0 €681 +€681
Recurring financial income 75 €0 €681 +€681
Financial charges 65/66B €17,839 €12,469 -€5,370 -30.1%
Recurring financial charges 65 €17,839 €12,469 -€5,370 -30.1%
Profit (loss) for the period before taxes 9903 €286,580 €319,048 +€32,468 +11.3%
Transfer from deferred taxes 780 €8,204 €8,204 +€0 0.0%
Income taxes 67/77 €80,940 €89,154 +€8,214 +10.1%
Profit (loss) for the period 9904 €213,844 €238,099 +€24,255 +11.3%
Transfer from tax-exempt reserves 789 €24,612 €24,613 +€1 0.0%
Profit (loss) for the period to be appropriated 9905 €238,457 €262,712 +€24,256 +10.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€987,386 to €1.3m

Midpoint €1.1m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €436,264
Capitalised earnings €1.5m to €2.2m
Indication €987,386 to €1.3m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€436,264
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€436,264

Capitalised earnings

net result for the year (9904)
2025
€238,099
2024
€213,844
2023
€194,230
2022
€654,145
excluding non-recurring income and charges
€58,727
2021
€122,525
Average result
€215,391
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.5m / €1.8m / €2.2m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.